AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
ABIOMED BOOSTS AVAILABILITY OF IMPELLA CIRCULATORY SUPPORT TECH.
(Full text of a statement. Contact details below.)
DANVERS, Mass.--(BUSINESS WIRE)--March 29, 2007--Abiomed, Inc. (NASDAQ: ABMD) today announced that the Office of the Drug Controller General (DCGI) in India has granted registration for the Company's Impella 2.5 and Impella 5.0 circulatory support technologies.
Abiomed plans to market these advanced medical devices through Interventional Technologies, Ltd, its distributor based in Mumbai, India.
"We are excited that interventional cardiologists in India will now have the opportunity to treat heart failure patients with the Impella circulatory support technologies," said V.M.
Kasim, Chairman & Managing Director, Interventional Technologies, Ltd., India.
The Impella 2.5 is a ventricular assist catheter, which is inserted percutaneously in the catheterization laboratory (cath lab) via the femoral artery into the left ventricle.
Up to 2.5 liters of blood per minute are delivered by the pump from the left ventricle into the ascending aorta, providing the heart with active support in critical situations.
- ABIOMED GRANTED APPROVAL FOR IMPELLA CIRCULATORY SUPPORT TECH.
- News wire article from: AsiaPulse News April 20, 2007 700+ words
...studies in the United States under an Investigational...IDE). The Impella 5.0 technology...studies in the United States under an Investigational...Exemption (IDE). Impella products are...investigational use in the United States. Other Impella devices and...
- Abiomed Expands Availability of Impella Circulatory Support Technologies.
- Press release article from: M2 Presswire March 29, 2007 700+ words
...pilot studies in the United States under an Investigational...Exemption (IDE). Impella products are investigational...investigational use in the United States and are not yet available...investigational use in the United States. Other Impella devices and the iPulse...
- Abiomed Expands Availability of Impella Circulatory Support Technologies with...
- Press release article from: Business Wire March 29, 2007 700+ words
...pilot studies in the United States under an Investigational...Exemption (IDE). Impella products are investigational...investigational use in the United States and are not yet available...investigational use in the United States. Other Impella devices and the iPulse...
- Abiomed Announces Australian Regulatory Approval of Impella Circulatory Support...
- Press release article from: Business Wire April 19, 2007 700+ words
...studies in the United States under an Investigational...IDE). The Impella 5.0 technology...studies in the United States under an Investigational...Exemption (IDE). Impella products are...investigational use in the United States. Other Impella devices and...
- Abiomed's Impella 2.5 Circulatory Support System Receives Medical Design...
- Press release article from: Business Wire April 9, 2007 700+ words
...abiomed.com. Impella products are investigational...investigational use in the United States and are not yet available...investigational use in the United States. Other Impella devices and the iPulse...available for sale in the United States. For additional ...
- ABIOMED Announces Expanded Reimbursement and Distribution in Europe for IMPELLA...
- Press release article from: Business Wire February 3, 2006 700+ words
...Recover (R) RD, and the IMPELLA Recover (R) LD which...investigational in the United States. The Company also announced...commenced shipment of IMPELLA technologies to customers...patient's heart. IMPELLA(R) RECOVER(R...investigational devices in the United States and are not ...
- Abiomed Receives Conditional FDA Approval for Impella 2.5 Study for Acute...
- Press release article from: Business Wire March 17, 2008 700+ words
...FDA) to begin its Impella([R])2.5 Circulatory...System study in the United States under an investigational...over $1 billion. The Impella 2.5 is also under...900 hospitals in the United States. The clinical experience to-date with Impella 2.5 has been favorable...
- ABIOMED Announces Data on Its Impella Recover LP 2.5 Presented at TCT.
- Press release article from: PR Newswire October 24, 2005 700+ words
...endure a sternotomy." IMPELLA DEVICES Impella products are investigational...investigational use in the United States and are not yet available...ABIOMED offers the Impella(R) Recover(TM...Exemption from the United States Food and Drug Administration...
Source: HighBeam Research, ABIOMED BOOSTS AVAILABILITY OF IMPELLA CIRCULATORY SUPPORT TECH.